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Abstract 
Research in human malaria disease has consistently been hindered in developing countries where this disease is 
endemic, due to the prohibitive cost of constructing and maintaining currently available experimental mouse 
models. Our goal, therefore, was to develop a cost-effective mouse model that may be used as research tool for 
studying human malaria disease. Plasmodium falciparum-infected human blood samples were cultured invitro for 
92 hours, and invivo malaria infection was induced by intraperitoneally injecting 0.5ml of the Plasmodium 
falciparum cultures into experimental mice, which were modified by the application of immunosuppressive and 
humanization protocols in which aspirin (4mg/kg), doxycycline (4mg/kg), and 0.5ml human blood that retained all 
of its cellular components (erythrocytes, leukocytes, and platelets) were repeatedly injected via the intraperitoneal 
route. Data obtained showed that the invitro-cultured Plasmodium falciparum significantly retained its infectivity 
and immunogenicity, since all the 20 mice inoculated exhibited peripheral blood parasitaemia. Quinine 
chemotherapy using standard antimalarial drug (73mg quinine/kg), however, induced significant suppression of 
the peripheral blood parasitaemia in the infected mice. Our results suggest that there is a substantial possibility of 
inducing and eradicating human malaria disease in our mouse model (humanized non-genetically manipulated 
mouse model) when used as a substitute for the conventional mouse models (humanized genetically manipulated 
mouse models).  
Keywords: Synchronized, Invitro, Invivo, Inocula, Immunosuppressed, Parasitaemia, Intraperitoneal,             
Infectivity.        
 
1. Introduction 
Malaria is an ancient disease that continues to cause enormous human morbidity and mortality.  It is caused by the 
erythrocyte stage of protozoan parasites of the genus - Plasmodium. Besides the challenges of multi-drug 
resistance posed by P. falciparum, a significant burden inhibiting the development of malaria research is the dearth 
of experimental non-human species for invivo studies of human-competent P. falciparum (Jimenez-Diaz et al., 
2009). Currently, laboratory mice are the only non-human models available for studying P. falciparum biology 
inside human erythrocytes.        
In studies conducted so far (Moreno et al., 2001; Arnold et al., 2011), mouse models used for human malaria 
research were constructed by the application of immunosuppression and humanization protocols. However, the 
cost implication of acquiring and maintaining the immunosuppressed mouse models currently available has 
retarded research activities in human malaria disease, especially in developing countries. The high cost 
encountered in constructing these immunosuppressed mouse models arises from: the highly specialized task 
involved in manipulating the genetics of the mouse strains; the non-easily accessible prescriptive pharmacological 
agents, for example, neutrophil marker monoclonal antibody (NIMP-R14), dexamethasone and 
cyclophosphamide, employed to complementarily inhibit innate defenses of the immunsouppressed mouse strains; 
as well as the specialized maintenance protocols required to sustain these mouse strains (Jimenez-Diaz et al., 2009; 
da Costa de Avila et al., 2012). 
Previous studies have also shown that relatively inexpensive easily accessible across-the-counter 
pharmacological agents, such as aspirin and doxycycline, exhibit immunosuppressive activities (Zhu et al., 2007; 
Leite et al., 2011). However, our study is, arguably, the first attempt to synergize the immunosuppressive effects of 
these two inexpensive easily accessible across-the-counter pharmacological agents (aspirin and doxycycline) to 
solely inhibit the innate defenses of non-genetically manipulated mouse strains; and to subsequently humanize the 
resultant immunosuppressed mouse strains by the engraftment of human blood that retained all of its cellular 
components (erythrocytes, leukocytes, and platelets). Our study, therefore, aims to develop a relatively 
inexpensive humanized non-genetically manipulated mouse model as a tool for studying human malaria disease.  
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2. Materials and Methods  
2.1 Invitro culture of Plasmodium falciparum 
2.1.1 Collection of human blood samples 
The human blood samples that showed malaria infection upon preliminary screening were collected from 
University of Benin Teaching Hospital (UBTH), Nigeria. Patients’ samples were collected following written 
informed consent, and ethical approval was obtained from the Igbinedion University Ethics Committee. 
2.1.2 Invitro culture set-up 
Invitro cultures were set up according to previously described standard procedure (Trager and Jensen, 1976), with 
slight modifications. Parasites were grown in group A
+
 heparinized blood cells (Igbinedion University Teaching 
Hospital (IUTH), Nigeria) in RPMI 1640 prototype medium (specially formulated by the authors of the present 
study) supplemented with 25mM NaHCO3 (BDH, England), 10mM glucose (BDH, England), 5.3ppm gentamycin 
(Greenfield Pharmaceutical Ltd, China), and 10% human serum (IUTH, Nigeria). Parasites were maintained at 5% 
haematocrit in the complete medium and incubated at room temperature (28±2
o
C) in candle jars for 46 hours.  
2.1.3 Synchronization of cultures after 46 hours incubation  
Synchronization was performed according to previously described standard method (Lambros and Vandenberg, 
1979). The infected cells and 5% sorbitol (Qualikems, India) were mixed using a dilution factor of 10, and kept at 
room temperature for 5 minutes, after which treated cells were washed thrice with complete medium by 
centrifugation (Centrifuge; PEC Medical, USA) at 400 x g for 4 minutes at room temperature. 
2.1.4 Invitro subculture set-up  
Invitro subcultures, which utilized the 46 hours synchronized cultures as inocula, were set up following similar 
procedure in 2.1.2. The subcultures were incubated for another 46 hours.  
2.1.5 Synchronization of subcultures after 46 hours incubation  
Subcultures were synchronized according to the method stated in 2.1.3. 
2.1.6 Dilution of synchronized subcultures 
Each synchronized subculture was diluted by mixing the culture with the complete medium and uninfected group 
A
+
 blood cells, after which, it was used as an inoculum to induce infection in the experimental mice. 
2.1.7 Evaluation of invitro cultures  
Blood films of cultures were examined for parasites according to the method of World Health Organization 
(WHO, 2009). Parasite count per microliter (µl) of blood was calculated according to this formula: 
     Number of parasites/µl =    
Number of parasites
       × white blood cell count/µl 
                               
Number of leukocytes counted 
Parasitaemia was also expressed as the percentage of red blood cells infected. 1% parasitaemia represented 50,000 
parasites /µl of blood (WHO, 2009).  
2.2 Development of mouse model 
2.2.1 Mice   
Non-genetically manipulated mice (21 - 31g) of both sexes were purchased from the Animal House in the 
University of Benin, Benin City, Nigeria. The mice were housed in standard mosquito-netted metal cages under 
standard conditions of light and temperature in the Animal Housing facility at Igbinedion University, Okada 
(IUO). They were maintained on standard diet and water ad libitum. The mice were acclimatized for 7 days and 
were treated in accordance with guidelines for animal care approved by the Animal Ethics Committee of the 
Igbinedion University. The mice were certified medically fit for the experiment by Dr. J. Danjuma, a veterinary 
doctor.  
2.2.2 Immunosuppression of mice   
Immunosuppression was carried out by an initial treatment (pre-treatment) of non-genetically manipulated mice 
with aspirin (4mg aspirin/kg body weight; Juhel Nig. Ltd, Nigeria) and doxycycline hydrochloride (4mg 
anhydrous doxycycline eq. /kg body weight; Vapi Care Pharm. Pvt. Ltd., India) for 20 days prior to humanization. 
Upon humanization, the resultant humanized immunosuppressed mice were repeatedly treated with similar 
dosages of aspirin and doxycycline throughout the duration of the study, and were only terminated upon demise of 
the mice. Aspirin and doxycycline were intraperitoneally injected into the mice.  
2.2.3 Humanization of immunosuppressed mice 
The immunosuppressed mice were initially engrafted with group O
+
 blood cells ( 0.5ml, 50% haematocrit) for 6 
days, followed by a repeated engraftment with group A
+
 blood cells (0.5ml, 50% haematocrit) for another 5 days. 
Upon inoculation of mice with P. falciparum cultures, mice were also daily transfused with group A
+
 blood cells 
throughout the duration of the study, and were only terminated upon demise of the mice. The human blood cells 
were intraperitoneally injected.  
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2.3 Infection of mouse model     
0.5ml diluted synchronized subcultures of P. falciparum served as inocula for infection of mice. Inocula were 
injected intraperitoneally into the mice after 11 days of engraftment with group O
+
 and A
+
 blood cells. Diluted 
subculture obtained from Sample A was inoculated into each mouse in test group 1; diluted subcultures obtained 
from Samples B, C, and D were also inoculated into each mouse in test groups 2, 3, and 4 respectively. Mice in the 
control group were not inoculated. 
2.3.1 Examination of blood films  
Thick and thin blood films of the cardiac and venous blood were examined for P. falciparum parasites according to 
the method of World Health Organization (WHO, 2009). 
2.4 Validation of the new mouse model for antimalarial chemotherapy studies   
Quinine was administered according to previously described standard procedure (Moreno et al., 2001). P. 
falciparum-infected mice that survived the malaria infection were divided into control and test groups 
respectively. Each mouse in the control group received an oral dose (4mg/kg) of placebo [dimethyl sulfoxide 
(DMSO)] three times daily for four days. Each mouse in the test group also received an oral dose (73mg/kg) of 
quinine three times daily for four days.  
2.4.1 Evaluation of antimalarial chemotherapy protocol  
Upon administration of quinine and DMSO, parasite densities were obtained from mice that either died or survived 
during the chemotherapy phase according to the method of World Health Organization (WHO, 2009). Net mean 
chemosuppression due to drug administration was calculated according to the formulation of Bassey et al. (2009), 
with slight modifications:            
    Net mean chemosuppression (%) =  
100 (A – B)   
 ˗
   
MC0 
                                         A                                                                       
Where,  
                     A =       Percentage of parasitaemia obtained in the mice administered with DMSO    
                     B =       Percentage of parasitaemia obtained in mice treated with quinine           
                  
100 (A – B)   
 = Mean chemosuppression 
                    
A
                               
                  MC0 =      Mean chemosuppression obtained from mice at day 0 of treatment. 
2.5 Statistical analysis 
All the values were expressed as mean and standard error of the mean. Chi-square test and regression analysis, 
where appropriate, were used to determine the level of significance, and P-value less than 0.05 (P < 0.05) were 
considered significant. The software SPSS version 16 was employed for the statistical analysis.    
 
3. Results  
3.1 Invitro culture of Plasmodium falciparum 
Table 1 represents parasitaemia obtained from the inocula, 92 hours synchronized invitro cultures, as well as their 
growth factors (degree of parasitaemia). The morphology of P. falciparum obtained from the invitro culture 
system is shown in the photomicrographs in Figure 1.   
3.2 Infection of mouse model 
Table 2 represents peripheral blood parasitaemia obtained from 25 humanized immunosuppressed mice which 
survived the first phase of this study (development of mouse model) and were, thus, selected for the infection 
phase. Figure 2 compared the parasitaemia obtained from each of the groups infected with each of the different 
human blood samples. Figure 3 represents photomicrographs of the peripheral blood of humanized 
immunosuppressed mice that died of malaria infection caused by P. falciparum, while Figure 4 shows 
photomicrographs of the peripheral blood of humanized immunosuppressed mice that survived malaria infection 
caused by P. falciparum.  
3.3 Antimalarial chemotherapy 
Table 3 represents parasitaemia and mean chemosuppression obtained from 12 P. falciparum-infected mice that 
survived the second phase (infection phase) of experiment, and were, thus, selected and used for the antimalarial 
chemotherapy validation phase. The effect of quinine/DMSO therapy on parasite suppression in the P. 
falciparum-infected mice is analysed in Figure 5.  
 
4. Discussion 
Our study describes a new approach of modifying mice to carry out studies on human diseases (with emphasis on 
malaria disease caused by human-competent Plasmodium falciparum). 
The invitro culture system employed in our study (Table 1) had significant similarities with the types used by 
other authors (Trager and Jensen, 1976; Moreno et al., 2001; Arnold et al., 2011). By using a non-genetically 
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manipulated mouse model, our study introduces a markedly different approach from previous studies (Moreno et 
al., 2001; Jimenez-Diaz et al., 2009; Arnold et al., 2011) which mainly utilized genetically manipulated mouse 
models as research tools for human malaria research. To optimally control inflammation in our mouse model, we 
employed pharmacological compounds (aspirin and doxycycline) that were also markedly different from the 
conventional compounds (neutrophil marker monoclonal antibody (NIMP-R14), dexamethasone, and 
cyclophosphamide) used in previous studies.  
The high parasite densities (Table 2) associated with the severe malaria infection may have overwhelmed the 
phagocytotic and necrotic effects of neutrophils (Arnold et al., 2011), thus, resulting in the sequestration of the P. 
falciparum parasites, and the ultimate death of some infected mice. In spite of the enormous innate defenses 
exerted in the peritonea of the mice inoculated with P. falciparum cultures, results obtained from our study showed 
that all the 20 mice inoculated with P. falciparum cultures at day 31 of experiment produced peripheral blood 
parasitaemia (Figure 2), indicating that some of the parasites survived by successfully circumventing the innate 
defenses mounted by peritoneal phagocytes. Parasite survival may be due to a significant attenuation of 
inflammatory responses, as a result of repeated intraperitoneal injection of the immunosuppressive drugs (Arnold 
et al., 2010). The receptivity by our immunosuppressed mice of  human erythrocyte component of the blood that 
were repeatedly injected into their peritonea, which provided a suitable habitat and nutrient for the parasites, may 
have also accounted for the parasites’ survival. Unlike the invitro culture system [Figure 1 (B and C)], where there 
was absence of spontaneous synchrony of the cultured P. falciparum, the invitro-cultured P. falciparum parasites, 
that entered the peripheral blood of mice employed in our study, exhibited remarkable spontaneous synchrony 
[Figure 3 (B and C); Figure 4 (A and B)]. Synchrony was, however, induced in the invitro culture system by 
treatment with 5% sorbitol. As indicated above in our study, all the results obtained from the infection phase 
significantly correlated with those recorded in humans (Arnold et al., 2011), thus, alluding to the potential 
immense value of this new mouse model for studying other human diseases.  
The new mouse model was validated for antimalarial chemotherapy research. Upon quinine therapy, our new 
mouse model showed significant apoptosis (P < 0.05) of P. falciparum parasites in the blood of peripheral and 
deep-seated capillaries when compared to DMSO therapy (Table 3; Figure 5), thus, significantly conforming to 
those obtained from previous studies (Moreno et al., 2001; Arnold et al., 2011 ).  
 
5. Conclusions 
Our study suggests that there is a substantial possibility of inducing and eradicating human diseases by using our 
mouse model, whose components of innate and adaptive immunity have been substantially substituted with those 
in humans through the repeated intraperitoneal injection of human blood that retained its leukocytes. Our results, 
therefore, corroborate the assertion of Arnold et al. (2010), who stated that “a deficiency in adaptive immunity is 
far from being enough to ensure the success of xenografts”.    
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Table 1.  Parasitaemia obtained from the invitro culture system 
Human                                 Parasite counts Growth 
blood       Inocula 92 hours synchronized    Diluted 92 hours factors 
Samples cultures     synchronized               
    cultures                       
(×10
3
cells/µl) (%) (×10
3
cells/µl) (%)  (×10
3
cells/µl)  (%)      
   A      24 0.48    2,040 40.8       400  8                    85 
B      36 0.72    2,003 40.06       400  8                    56 
C     33.2 0.66    1,941 38.82       400  8                  59 
D     20.64 0.41    1,796 35.91       400  8                    87 
 
As recorded in Table 1, varying parasite densities (0.41% to 0.48%) were obtained from the four different P. 
falciparum-infected samples (A – D) used as inocula for the invitro cultures. After 92 hours of incubating 
synchronized cultures of the blood samples, parasite densities (35.91% to 40.8%) obtained from the invitro 
cultures were markedly different from values of their inocula. Sample D had the highest growth factor (87- fold 
increase), while the lowest growth factor (56-fold increase) was recorded in sample B. All the synchronized invitro 
subcultures were, however, diluted using different dilution factors (5.1, 5, 4.85, 4.51 for Samples A, B, C, and D 
respectively), so as to obtain invitro cultures with the same parasite densities (8%), from which equivalent volume 
(0.5ml) were used as inocula for invivo infection of mice.     
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Table 2. Parasitaemia obtained from immunosuppressed mice infected with P. falciparum    
Days of    Mice Inoculum    Mean parasite counts           Overall mean parasite counts 
infection employed (× 10
3
 cells/µl)      (%) (× 10
3
 cells/µl) (%) 
 
0 Control group None (-)    0 ±0    0 ±0    0 ±0           0 ±0 
Test group 1 Sample A    0 ±0         0±0      0±0    0±0 
Test group 2 Sample B    0 ±0         0±0 
Test group 3 Sample C    0 ±0         0±0 
Test group 4 Sample D    0 ±0         0±0 
2 Control group     -    0 ±0         0±0      0±0    0±0 
Test group 1     * 13.5 ±0.69      0.27 ±0.01   18.8 ±4.2 0.38 ±0.08 
Test group 2     * 16 ±0.62      0.32±0.01 
Test group 3     * 31.3 ±14.2      0.63 ±0.28 
Test group 4     * 14.4 ±0.68      0.29 ±0.01 
4 Control group     -     0±0    0±0      0±0           0±0 
Test group 1     * 55.4 ±16.8 1.11 ±0.34   43.8±5.97       1±0.17 
Test group 2     * 43.1 ±3.94 1.36 ±0.57 
Test group 3     * 49.2 ±1.39 0.99 ±0.03 
Test group 4     * 27.6 ±2.76 0.55 ±0.05 
6 Control group     -     0±0    0±0      0±0           0±0 
Test group 1     *  64.6 ±24.3 1.29 ±0.49   48.2±6.96     0.97±0.14 
Test group 2     * 39.4 ±5.06 0.79 ±0.1 
Test group 3     * 54.5 ±0.22 1.1 ±0.01 
Test group 4     * 34.3 ±1.64 0.69 ±0.03 
(*) indicates that mice were only inoculated with the invitro P. falciparum cultures at day 0 of infection. All values 
represent mean ± standard error mean (SEM).  
Unlike in the control group (Table 2), where the mice remained uninfected (mean parasite count at day 0 to 6 of 
infection = 0%), all the mice in the test groups (Table 2) were markedly infected, as indicated by the overall mean 
parasite counts (0%; 0.38±0.08%; 1±0.17%; 0.97±0.14%) obtained at days 0, 2, 4 and 6 of infection respectively.   
 
Table 3.  Parasitaemia obtained from infected mice treated with quinine and dimehyl sulfoxide 
Days of    Mice Drugs admin-   Mean parasite counts Mean chemo-     Net      
therapy istered (× 10
3
 cells/µl)   (%) suppression   MC   
    (%)   (%)        
       
       
0 Control group   DMSO   77.05±3.18  1.54±0.06     1.19    0 
Test group   Quinine   76.14±4.45 1.52±0.09 
2 Control group   DMSO   80.79±2.6 1.62±0.05    60.67 59.49 
Test group   Quinine   80.95±1.28 0.64±0.03 
4 Control group   DMSO   83.58±15.94 1.67±0.32    83.82 82.65 
Test group   Quinine   13.52±0.57 0.27±0.01        
Net MC represents net mean chemosuppression; DMSO represents dimethyl sulfoxide. 
In the group of mice treated with quinine (Table 3), parasite counts were estimated at 1.52±0.09% and 
0.27±0.012% at days 0 and 4 of therapy respectively; while in the group treated with DMSO (Table 3), parasite 
counts were estimated at 1.542±0.063% and 1.672±0.32% at days 0 and 4 of therapy respectively. 
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Figure 1.   Photomicrographs obtained from invitro culture of Plasmodium falciparum 
In Figure 1A, the photomicrograph (Sample A) of the P. falciparum-infected human blood sample showed a 
predominance of matured P. falciparum trophozoites, lymphocytes, and monocytes. The photomicrographs of 
other samples (Samples B, C, and D) had similar patterns with that shown in Figure 1A. Photomicrograph of the 
synchronized invitro culture obtained from Sample A, after 92 hours incubation, is shown in Figure 1B. It showed 
exponential proliferation of the parasites, with a vast majority being at the same stage of growth. The other samples 
(B, C, and D) also exhibited similar patterns with that shown in Figure 1B. Figure 1C represents photomicrograph 
of a diluted synchronized invitro culture obtained from Sample A, which was used for the infection of 
experimental mice in test group 1. 
 
 
Figure 2.  Invivo parasitaemia patterns exhibited by cultures obtained from the different         
clinical blood samples which were each respectively used as an inoculum to infect 5 humanized 
immunosuppressed mice in each of the experimental group 
As shown in Figure 2, the mice in group 3 inoculated with synchronized cultures obtained from blood sample C 
had the highest parasite counts, with peak parasitaemia level attaining 1.63% at day 5 of infection; while the least 
parasite counts were recorded in the mice in group 4 (parasitaemia level = 0.68% at day 6 of infection) which were 
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inoculated with synchronized cultures obtained from blood sample D. There were large variations in the parasite 
densities of some mice in each of the groups infected with invitro cultures obtained from the different human 
samples, as indicated by the values of their standard errors. These variations arose from the very high parasite 
counts obtained from the cardiac blood films of the mice that died of malaria infection, as compared to the 
relatively low parasite counts obtained from the venous blood films of mice that survived the malaria infection 
phase in each experimental group. 
 
Figure 3.  Photomicrographs of the peripheral blood of humanized immunosuppressed mice that died of  malaria 
infection caused by P. falciparum 
 
 
Figure 4.  Photomicrographs of the peripheral blood of a humanized sub-chronic immunosuppressed mouse that 
survived malaria infection caused by P. falciparum. 
When the photomicrograph obtained from mice that died of malaria infection caused by P. falciparum at day 2 and 
4 after infection [(Figure 3 (B and C)] were compared to that obtained from a mouse that were injected with P. 
falciparum at day 0 of infection (Figure 3A), the micrographs showed that the peripheral blood of infected mice 
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were morphologically altered. Photomicrograph obtained from infected mice that survived the infection phase, as 
shown in Figure 4 (A and B), also showed a morphologically altered peripheral blood. As shown in Figure 3A, 
significant proportions of intact erythrocytes were seen in the peripheral blood of the humanized 
immunosuppressed mice immediately after they were intraperitoneally injected with malaria parasites. However, 
upon infection, cardiac and venous blood films obtained from infected mice that either died [Figure 3 (B and C)] or 
survived [Figure 4 (A and B)] revealed a proliferation of lymphocytes, monocytes, and trophozoites of P. 
falciparum that were largely at the same stage of growth; though, relatively low parasite densities were seen in the 
venous blood of mice that survived, when compared to those seen in the cardiac blood of mice that died of malaria 
infection. Remarkably, the photomicrographs shown in Figure 3 (B and C) and Figure 4 (A and B) obtained from 
mice significantly resembled the photomicrograph shown in Figure 1A obtained from a human blood sample 
infected with P. falciparum. 
 
Figure 5.  Effect of antimalarial therapy on P. falciparum suppression in the infected immunosuppressed mouse 
model (r= 0.98, P < 0.05) 
According to the regression graph shown in Figure 5, quinine was well tolerated in the new mouse model, and 
exhibited a highly potent effect, by significantly clearing (P < 0.05) the parasitaemia of the infected mice in the test 
groups, as indicated by net mean chemosuppression of 0% and 82.65% at days 0 and 4 of antimalarial therapy 
respectively. 
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